Showing 1 - 10 of 798
Persistent link: https://www.econbiz.de/10010345456
The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...
Persistent link: https://www.econbiz.de/10012802183
Persistent link: https://www.econbiz.de/10012439514
Persistent link: https://www.econbiz.de/10011963838
Persistent link: https://www.econbiz.de/10012208081
This WTO working paper studies availability and affordability of new and innovative pharmaceuticals in a post-TRIPS era … the introduction of product patents in pharmaceuticals affect the likelihood of pharmaceutical firms to launch new and … finds that introduction of product patent for pharmaceuticals in the patent law has a positive effect on launch likelihood …
Persistent link: https://www.econbiz.de/10011992779
Persistent link: https://www.econbiz.de/10013466790
Persistent link: https://www.econbiz.de/10003756813
Persistent link: https://www.econbiz.de/10003410196
This paper explores the academic literature and empirical evidence associated with the strategic and tactical opportunities available to pharmaceutical firms confronted with the loss of patent protection on their branded drug. The marketing dimensions of product innovation, pricing and brand...
Persistent link: https://www.econbiz.de/10013099957